Bausch Health Companies | VRX - Loan Capital

Stock Price
8.18
Daily Change
-0.09 -1.09%
Monthly
6.23%
Yearly
-23.91%
Q1 Forecast
8.16

Bausch Health Companies reported $20.62B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Amgen USD 50B 2.43B Dec/2025
ANI Pharmaceuticals USD 291.84M 5.84M Dec/2025
Aurora Cannabis CAD 34.99M 1.31M Sep/2025
Bausch Health Companies USD 20.62B 152M Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Canopy Growth CAD 226.33M 62.67M Sep/2025
Danaher USD 18.42B 1.58B Dec/2025
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Novo Nordisk DKK 118.94B 29.76B Dec/2025
Pacira USD 372.19M 4.53M Dec/2025
Perrigo USD 3.6B 4.5M Dec/2025
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025
Zoetis USD 9.04B 1.97B Dec/2025